{
    "medicine_id": "5da6c8246f1a2c2b16be816d0db920d7818b98f5",
    "platform_id": "DB05652",
    "metadata": {
        "name": "Le Blen FGF Serum 100 mg ml Injection",
        "composition": "100 mg ml VTP 201227",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in psoriasis and psoriatic disorders",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "VTP 201227 is a potent selective inhibitor of two specific enzymes that are active in the skin Therapeutic targeting of these enzymes by VTP 201227 promotes naturally occurring healing processes within the skin The compound has been designed to be rapidly inactivated in systemic circulation and thus has the potential to have a more favorable safety profile In preclinical animal models VTP 201227 was shown to exhibit a superior therapeutic index compared to other topical dermatology drugs",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}